MariMed CEO Fireman To Speak on Public Cannabis Company Analysis at Kahner Global's Cannabis Private Investment Summit
Fireman, CEO of 2018 Top Performing Cannabis Stock, will share insight on what it takes to lead the market in stock performance
Newton, MA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB MRMD) CEO Robert Fireman will be a featured panelist at Kahner Global's Cannabis Private Investment Summit in New York City, NY, on September 13th. The panel, titled “Analysis of Public Cannabis Companies,” is moderated by Murray Huneke, Managing Director, North Point Advisors. Panelists include:
- Robert Fireman, CEO, MariMed Inc.
- Steve Klein, Chairman, Flowr
- Christian Hageseth, Chairman & CEO, ONE Cannabis
- Sean Stiefel, Navy Capital
As founder of multiple successful start-ups and now MariMed Inc., a multi-state professional cannabis organization that owns, manages cannabis facilities and manufactures, licenses top brands and innovative products, Fireman has successfully navigated the challenges of raising capital and developing strategy to grow from initial stages to a publicly traded company. MariMed was recently named The Best Performing Marijuana Stock in 2018 by Fresh Toast, one of the 3 Best Cannabis Stocks of 2018 by Motley Fool, and one of five Top Cannabis Stocks to Watch by High Times. MariMed has developed and manages 11 facilities in six states, has three more facilities under development, has its branded products distributed in seven states, and boasts a market cap of approximately $525 million.
During the panel, Fireman will address key factors investors should consider when analyzing cannabis stocks, discuss some of the advantages and challenges of being a public company, and share insights on the best investment opportunities and themes in the rapidly evolving cannabis market.
MariMed is a Bronze Sponsor for the Summit, which brings together the best and brightest cannabis entrepreneurs, ultra high net worth investors, and family offices in a premier, curated, invitation-only event that is considered “The Tiffany’s of investment conferences for cannabis” by JJ McKay, Founder of Fresh Toast. The sold-out conference includes a high profile line-up of speakers including Montel Williams, Founder, Lenitiv Scientific, Cannabis Advocate and Emmy Award Winning Television Personality and Larry Sharpe, Candidate for Governor of New York.
Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
# # #
About MariMed Inc.:
MariMed is a multi-state professional cannabis organization that develops, owns and manages cannabis facilities and branded products lines. MariMed’s team has developed state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI, which are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision-dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional markets encompassing thousands of dispensaries. MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com). For additional information, visit www.MariMedAdvisors.com
Forward Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.
Media Contacts: For MariMed Business Development Jon Levine, CFO, MariMed info@MariMedAdvisors.com 781-559-8713 Investor Relations Tyler Troup, Circadian Group email@example.com +1 (866) 950 8300 Media Relations Julie Shepherd, Accentuate PR Julie@accentuatepr.com 847-275-3643
Released September 12, 2018